Industry

– Overview of two decades of research to be presented, including development of gantenerumab – – Detailed results from Phase II study evaluating crenezumab in autosomal dominant Alzheimer’s disease – – Data around biomarker selection for the Elecsys Amyloid Plasma Panel, a blood-based biomarker test to aid in the detection of people with amyloid pathology, … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its initial public offering of 2,000,000 shares of the Company’s common stock at a public offering price of $5.00 per share for aggregate gross proceeds of $10,000,000 prior to deducting underwriting … [Read more…]

AI-powered Viz SDH automatically detects subdural hemorrhage, enables effective triage and optimal care SAN FRANCISCO–(BUSINESS WIRE)–#AI–Insert after fourth paragraph of release: footnote 2. The updated release reads: VIZ.AI RECEIVES FDA 510(K) CLEARANCE FOR VIZ SDH AI-powered Viz SDH automatically detects subdural hemorrhage, enables effective triage and optimal care Viz.ai, the leading AI-powered disease detection and … [Read more…]

HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2022. Quarter ended June 30, 2022* Highlights ─ compared to June 30, 2021 Net sales increased $9.6 million, or 6.5%, to $156.7 million. Gross profit of $81.6 million (52.1% of net sales) … [Read more…]

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 second quarter operational and financial results after market hours on August 2, 2022. SECOND QUARTER 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 … [Read more…]

The highly anticipated keynote lineup will explore breaking into the biomedical space, digital health advancements, patents in the medical device field, and more. All keynotes are free for BIOMEDevice Boston registered guests. Secure a pass to BIOMEDevice Boston here. BOSTON–(BUSINESS WIRE)–#BIOMEDevice–Theranos whistleblower Erika Cheung, Segway inventor and co-founder Dean Kamen, and a panel of senior-level … [Read more…]

Company to present results of validation study at 2022 Alzheimer’s Association International Conference BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced the validation of a laboratory developed test (LDT) to quantitatively measure phospho-Tau 181 (pTau-181) in plasma as an aid in diagnostic evaluation of … [Read more…]

BROOKLYN, N.Y.–(BUSINESS WIRE)–#BusinessPartnership—Dialyze Direct, the nation’s leading provider of home hemodialysis services in Skilled Nursing Facilities (SNFs), announced today it has partnered with CommuniCare Family of Companies, one of the nation’s largest post-acute care providers, to conduct onsite hemodialysis services at its facilities around the U.S. Founded in 1984 on the philosophy of “Serving with … [Read more…]

CHICAGO–(BUSINESS WIRE)–BioGX, a global provider of easy molecular diagnostic solutions, announced the launch of a point-of-care (POC) CE-Marked, three gene multiplex COVID-19 test on its pixl platform. The test utilizes BioGX’s highly successful Xfree direct sample testing chemistry that is included in its US FDA emergency use authorized Xfree COVID-19 Direct RT-PCR test. This new … [Read more…]

MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022. Xencor management will host a webcast and conference call the same day at … [Read more…]